Validation of the AmpC β-lactamase binding site and identification of inhibitors with novel scaffolds

Journal of Chemical Information and Modeling
Fung-Yi ChanKwok-Yin Wong

Abstract

AmpC β-lactamase confers resistance to β-lactam antibiotics in multiple Gram-negative bacteria. Therefore, identification of non-β-lactam compounds that inhibit the enzyme is considered crucial to the development of novel antibacterial therapies. Given the highly solvent-exposed active site, it is important to study the induced-fit movements and water-mediated interactions to improve docking accuracy and virtual screening enrichments in structure-based design of new AmpC inhibitors. Here, we tested multiple models of the AmpC binding site to investigate the importance of conserved water molecules and binding site plasticity on molecular docking. The results indicate that at least one conserved water molecule greatly improves the binding pose predictions and virtual screening enrichments of known noncovalent AmpC inhibitors. The best model was tested prospectively in the virtual screening of about 6 million commercially available compounds. Sixty-one chemically diverse top-scoring compounds were experimentally tested, which led to the identification of seven previously unknown inhibitors. These findings validate the essential features of the AmpC binding site for molecular recognition and are useful for further optimization of i...Continue Reading

References

Aug 21, 1992·Science·H C Neu
May 1, 1991·The Biochemical Journal·J Rahil, R F Pratt
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·C H O'CallaghanA H Shingler
Jan 1, 1983·Annual Review of Biochemistry·D J Waxman, J L Strominger
Jan 1, 1983·The Biochemical Journal·T BeesleyT Grundström
Apr 1, 1993·Antimicrobial Agents and Chemotherapy·K BushY Yang
Feb 1, 1993·Antimicrobial Agents and Chemotherapy·P M Bennett, I Chopra
Jan 1, 1997·Trends in Microbiology·R E Hancock
Aug 4, 1998·The Journal of Antimicrobial Chemotherapy·D M Livermore
Jul 1, 1999·Protein Science : a Publication of the Protein Society·T R KillickA R Fersht
Dec 14, 1999·Protein Science : a Publication of the Protein Society·R A PowersB K Shoichet
Aug 11, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Malcolm G. P. Page
Apr 5, 2002·Journal of Medicinal Chemistry·Susan L McGovernBrian K Shoichet
May 4, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael BarzaStephen J DeVincent
Jul 12, 2002·Journal of Medicinal Chemistry·Rachel A Powers, Brian K Shoichet
Jul 18, 2002·Structure·Rachel A PowersBrian K Shoichet
Dec 11, 2003·Microbiology and Molecular Biology Reviews : MMBR·Hiroshi Nikaido
Dec 4, 2004·Nature Medicine·Stuart B Levy, Bonnie Marshall
May 27, 2005·Journal of Medicinal Chemistry·Alan P GravesBrian K Shoichet
Aug 1, 2006·Trends in Microbiology·David M Livermore, Neil Woodford
Oct 31, 2006·Nature Chemical Biology·Kerim Babaoglu, Brian K Shoichet
Dec 13, 2006·Journal of Medicinal Chemistry·Niu HuangJohn J Irwin
Mar 13, 2008·Journal of Medicinal Chemistry·Kerim BabaogluBrian K Shoichet
Aug 6, 2008·Journal of Medicinal Chemistry·Niu Huang, Brian K Shoichet
Jan 13, 2009·Clinical Microbiology Reviews·George A Jacoby
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Denise G TeoticoBrian K Shoichet
Nov 28, 2009·Current Medicinal Chemistry·Giulia MorraGiorgio Colombo
Apr 5, 2011·Critical Care : the Official Journal of the Critical Care Forum·Matteo BassettiMalgorzata Mikulska
Nov 15, 2011·Nucleic Acids Research·Irina KufarevaRuben Abagyan

❮ Previous
Next ❯

Citations

Jan 23, 2016·Journal of Chemical Information and Modeling·Yan LiRen-Xiao Wang
Apr 29, 2015·Proceedings of the National Academy of Sciences of the United States of America·Dima KozakovSandor Vajda
May 4, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Ning SunKwok-Yin Wong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Denise G TeoticoBrian K Shoichet
Antimicrobial Agents and Chemotherapy
Beth M Beadle, Brian K Shoichet
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
M RylanderS R Norrby
© 2021 Meta ULC. All rights reserved